HI
DMRA

Harbour Investments’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Harbour Investments’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04K Buy
+40
New +$1.03K ﹤0.01% 4092
2024
Q4 		– Sell
-8
Closed -$97 – 3529
2024
Q3 		$97 Hold
8
– – ﹤0.01% 3313
2024
Q2 		$95 Hold
8
– – ﹤0.01% 3209
2024
Q1 		$156 Buy
+8
New +$142 ﹤0.01% 3129
2021
Q4 		– Sell
-12
Closed -$1K – 3051
2021
Q3 		$1K Hold
12
– – ﹤0.01% 3508
2021
Q2 		$2K Buy
12
+8
+200% +$1.09K ﹤0.01% 3376
2021
Q1 		$1K Buy
+4
New +$1.09K ﹤0.01% 3386

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

Harbour Investments's DMRA Position: Q1 2026 in Review

Harbour Investments opened a new position in Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q1 2026: 40 shares worth $1.04K. The stake represents ﹤0.01% of the portfolio and ranks #4092 among its holdings. This is a return to the name: Harbour Investments previously reported a position in DMRA as recently as Q3 2024.

Harbour Investments first reported a position in DMRA in Q1 2021 and has held it in 7 quarters since. The position peaked at $2K in Q2 2021. 65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

  • Harbour Investments held 40 shares of Damora Therapeutics, Inc. Ordinary Shares worth $1.04K as of Q1 2026.
  • Damora Therapeutics, Inc. Ordinary Shares was a new Harbour Investments position in Q1 2026.
  • Damora Therapeutics, Inc. Ordinary Shares made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4092 holding.
  • Harbour Investments first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q1 2021 and has held it in 7 quarters since.
  • Harbour Investments's Damora Therapeutics, Inc. Ordinary Shares position peaked at $2K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.